Nechama, Morris
Kwon, Jeahoo
Wei, Shuo
Tun-Kyi, Adrian
Welner, Robert S.
Ben-Dov, Iddo Z. http://orcid.org/0000-0002-9180-3604
Arredouani, Mohamed S.
Asara, John M.
Chen, Chun-Hau
Tsai, Cheng-Yu
Nelson, Kyle F.
Kobayashi, Koichi S
Israel, Elliot
Zhou, Xiao Zhen
Nicholson, Linda K.
Lu, Kun Ping
Article History
Received: 14 July 2017
Accepted: 21 March 2018
First Online: 23 April 2018
Competing interests
: K.P.L. and X.Z.Z. are inventors of Pin1 technology including patents and patent application on tau antibodies, which was licensed by BIDMC to Pinteon Therapeutics. Both K.P.L. and X.Z.Z. own equity in, and consult for, Pinteon. Their interests were reviewed and are managed by BIDMC in accordance with its conflict of interest policy. K.P.L. and X.Z.Z. did not intervene or interact with, obtain consent from, or have access to identifiable private information or identifiable specimens from the human specimen donors for research purposes. The remaining authors declare no competing interests.